Purchase Order HHSN272201600159P
Award Date 12/4/15
Potential Completion Date 12/13/20
Potential Value $146K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. for a maintenance service contract on various Illumina sequencing instruments. The contract has a period of performance from November 30, 2015 to November 29, 2016, with four one-year option periods, for a total potential value of $128,638. The contract does not have a set-aside designation....
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The contract, valued at $12,875.00, is for sequencing services to support NIAID's research and diagnostic efforts. Illumina has previously been awarded other prime federal contracts and subcontracts by...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of genomic analysis technologies. The $249,519.59 contract is for a service agreement to provide multiple Illumina DNA sequencers over a 1-year period from August 28, 2025 to August 27, 2026. The contract does not utilize a set-aside designation. Illumina is a...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for maintenance services on Illumina sequencing equipment. The contract has a ceiling value of $54,048.00 and was awarded on March 11, 2015, with a period of performance ending on April 8, 2016. Illumina is a manufacturer of genetic and genomic analysis instruments and reagents, and has previously provided...
- This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions. The $52,300 award is for the provision of a Genome Analyzer instrument and related service agreement, with a period of performance ending on April 10, 2015. There was no set-aside designation for this contract. Illumina has a history of providing...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. The $5,636.16 contract is for the delivery of Illumina's sequencing systems, reagents, and services to support genomic research and analysis. Illumina, a manufacturer of genetic analysis instruments and consumables, has previously been awarded prime contracts and sub-awards across various federal agencies...
- This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the provision of sequencing kits, with a ceiling value of $7,012.50 and a period of performance from May 15, 2014 to May 23, 2014. The contract has no set-aside designation. Illumina has a history of providing...
- This is a $6,935.22 firm fixed-price purchase order contract awarded to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions, by the National Institute of Allergy and Infectious Diseases (NIAID), an agency of the National Institutes of Health (NIH). The contract, which has no set-aside designation, is for the provision of sequencing systems, reagents, and services to support genomic research and diagnostics across various federal agencies. Illumina has...
- This firm fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing and analysis instruments and reagents. The $50,000 contract is for the provision of sequencing systems, consumables, and support services to assist with genomic research and diagnostics. Illumina has a history of providing these types of products and services to...
- This is a firm fixed-price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. for the provision of Illumina biomedical sequencing instruments and related materials. The $7,998.65 contract is for the purchase of Illumina's sequencing systems, reagents, and consumables to support genomic research and diagnostics. Illumina is a leading manufacturer of genetic analysis...